91 related articles for article (PubMed ID: 16725145)
1. Troglitazone inhibits oxidized low-density lipoprotein-induced macrophage proliferation: impact of the suppression of nuclear translocation of ERK1/2.
Yano M; Matsumura T; Senokuchi T; Ishii N; Motoshima H; Taguchi T; Matsuo T; Sonoda K; Kukidome D; Sakai M; Kawada T; Nishikawa T; Araki E
Atherosclerosis; 2007 Mar; 191(1):22-32. PubMed ID: 16725145
[TBL] [Abstract][Full Text] [Related]
2. Statins suppress oxidized low density lipoprotein-induced macrophage proliferation by inactivation of the small G protein-p38 MAPK pathway.
Senokuchi T; Matsumura T; Sakai M; Yano M; Taguchi T; Matsuo T; Sonoda K; Kukidome D; Imoto K; Nishikawa T; Kim-Mitsuyama S; Takuwa Y; Araki E
J Biol Chem; 2005 Feb; 280(8):6627-33. PubMed ID: 15611087
[TBL] [Abstract][Full Text] [Related]
3. Activation of AMP-activated protein kinase suppresses oxidized low-density lipoprotein-induced macrophage proliferation.
Ishii N; Matsumura T; Kinoshita H; Motoshima H; Kojima K; Tsutsumi A; Kawasaki S; Yano M; Senokuchi T; Asano T; Nishikawa T; Araki E
J Biol Chem; 2009 Dec; 284(50):34561-9. PubMed ID: 19843515
[TBL] [Abstract][Full Text] [Related]
4. Extracellular signal-regulated kinase and p38 mitogen-activated protein kinase mediate macrophage proliferation induced by oxidized low-density lipoprotein.
Senokuchi T; Matsumura T; Sakai M; Matsuo T; Yano M; Kiritoshi S; Sonoda K; Kukidome D; Nishikawa T; Araki E
Atherosclerosis; 2004 Oct; 176(2):233-45. PubMed ID: 15380445
[TBL] [Abstract][Full Text] [Related]
5. 15d-PGJ2 inhibits oxidized LDL-induced macrophage proliferation by inhibition of GM-CSF production via inactivation of NF-kappaB.
Matsuo T; Matsumura T; Sakai M; Senokuchi T; Yano M; Kiritoshi S; Sonoda K; Kukidome D; Pestell RG; Brownlee M; Nishikawa T; Araki E
Biochem Biophys Res Commun; 2004 Feb; 314(3):817-23. PubMed ID: 14741709
[TBL] [Abstract][Full Text] [Related]
6. Group-II phospholipase A(2) enhances oxidized low density lipoprotein-induced macrophage growth through enhancement of GM-CSF release.
Kaneko K; Sakai M; Matsumura T; Biwa T; Furukawa N; Shirotani T; Kiritoshi S; Anami Y; Matsuda K; Sasahara T; Shichiri M
Atherosclerosis; 2000 Nov; 153(1):37-46. PubMed ID: 11058698
[TBL] [Abstract][Full Text] [Related]
7. Induction of murine macrophage growth by oxidized low density lipoprotein is mediated by granulocyte macrophage colony-stimulating factor.
Biwa T; Hakamata H; Sakai M; Miyazaki A; Suzuki H; Kodama T; Shichiri M; Horiuchi S
J Biol Chem; 1998 Oct; 273(43):28305-13. PubMed ID: 9774454
[TBL] [Abstract][Full Text] [Related]
8. Troglitazone and rosiglitazone inhibit the low density lipoprotein-induced vascular smooth muscle cell growth.
Gouni-Berthold I; Berthold HK; Weber AA; Seul C; Vetter H; Sachinidis A
Exp Clin Endocrinol Diabetes; 2001; 109(4):203-9. PubMed ID: 11453032
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid inhibits oxidized LDL-induced macrophage growth by suppressing the expression of granulocyte/macrophage colony-stimulating factor.
Sakai M; Biwa T; Matsumura T; Takemura T; Matsuda H; Anami Y; Sasahara T; Kobori S; Shichiri M
Arterioscler Thromb Vasc Biol; 1999 Jul; 19(7):1726-33. PubMed ID: 10397691
[TBL] [Abstract][Full Text] [Related]
10. Dopamine D1-Like Receptors Suppress the Proliferation of Macrophages Induced by Ox-LDL.
Yao Y; Yang D; Han Y; Wang W; Wang N; Yang J; Zeng C
Cell Physiol Biochem; 2016; 38(1):415-26. PubMed ID: 26824460
[TBL] [Abstract][Full Text] [Related]
11. Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice: pleiotropic effects on CD36 expression and HDL.
Chen Z; Ishibashi S; Perrey S; Osuga Ji ; Gotoda T; Kitamine T; Tamura Y; Okazaki H; Yahagi N; Iizuka Y; Shionoiri F; Ohashi K; Harada K; Shimano H; Nagai R; Yamada N
Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):372-7. PubMed ID: 11231916
[TBL] [Abstract][Full Text] [Related]
12. Comparison of macrophage responses to oxidized low-density lipoprotein and macrophage colony-stimulating factor (M-CSF or CSF-1).
Hamilton JA; Byrne R; Jessup W; Kanagasundaram V; Whitty G
Biochem J; 2001 Feb; 354(Pt 1):179-87. PubMed ID: 11171093
[TBL] [Abstract][Full Text] [Related]
13. Sites of action of protein kinase C and phosphatidylinositol 3-kinase are distinct in oxidized low density lipoprotein-induced macrophage proliferation.
Biwa T; Sakai M; Matsumura T; Kobori S; Kaneko K; Miyazaki A; Hakamata H; Horiuchi S; Shichiri M
J Biol Chem; 2000 Feb; 275(8):5810-6. PubMed ID: 10681570
[TBL] [Abstract][Full Text] [Related]
14. Effects of ciglitazone and troglitazone on the proliferation of human stomach cancer cells.
Cheon CW; Kim DH; Kim DH; Cho YH; Kim JH
World J Gastroenterol; 2009 Jan; 15(3):310-20. PubMed ID: 19140230
[TBL] [Abstract][Full Text] [Related]
15. Electronegative L5-LDL induces the production of G-CSF and GM-CSF in human macrophages through LOX-1 involving NF-κB and ERK2 activation.
Yang TC; Chang PY; Kuo TL; Lu SC
Atherosclerosis; 2017 Dec; 267():1-9. PubMed ID: 29078142
[TBL] [Abstract][Full Text] [Related]
16. Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice.
Collins AR; Meehan WP; Kintscher U; Jackson S; Wakino S; Noh G; Palinski W; Hsueh WA; Law RE
Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):365-71. PubMed ID: 11231915
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylated troglitazone activates PPARgamma and inhibits vascular smooth muscle cell proliferation and proteoglycan synthesis.
Little PJ; Ballinger ML; Survase S; Osman N; Ogru E; Geytenbeek S; Bruemmer D; Nigro J
J Cardiovasc Pharmacol; 2008 Mar; 51(3):274-9. PubMed ID: 18356692
[TBL] [Abstract][Full Text] [Related]
18. Oxidized low-density lipoprotein activates adipophilin through ERK1/2 signal pathway in RAW264.7 cells.
Liu Q; Dai Z; Liu Z; Liu X; Tang C; Wang Z; Yi G; Liu L; Jiang Z; Yang Y; Yuan Z
Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):635-45. PubMed ID: 20710016
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte/macrophage colony-stimulating factor plays an essential role in oxidized low density lipoprotein-induced macrophage proliferation.
Biwa T; Sakai M; Shichiri M; Horiuchi S
J Atheroscler Thromb; 2000; 7(1):14-20. PubMed ID: 11425039
[TBL] [Abstract][Full Text] [Related]
20. Troglitazone inhibits long-term glycation and oxidation of low-density lipoprotein.
Sobal G; Menzel EJ; Sinzinger H
J Cardiovasc Pharmacol; 2005 Nov; 46(5):672-80. PubMed ID: 16220075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
